Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2006-07-14
2009-08-18
Rawlings, Stephen L (Department: 1643)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S350000, C530S387100, C530S387300, C530S387700, C530S388240, C530S389100, C530S391300
Reexamination Certificate
active
07576187
ABSTRACT:
An isolated polynucleotide at least 60% homologous to SEQ ID NO: 1, 3, 5 or 18 encoding a SARP polypeptide; vectors comprising a polynucleotide sequence encoding at least 11 consecutive amino acids of αSARP polypeptide; a host cell transformed with an isolated polynucleotide or vector; antibodies specific for SARP and use of such polynucleotides and antibodies in diagnostic and therapeutic method. Therapeutic uses of antibodies and polynucleotides of sarp. Methods for treating diseases related to the regulation of SARP expression in tissue and bodily fluid samples, including cancers.
REFERENCES:
patent: 3817837 (1974-06-01), Rubenstein et al.
patent: 3850752 (1974-11-01), Schuurs et al.
patent: 3939350 (1976-02-01), Kronick et al.
patent: 3996345 (1976-12-01), Ullman et al.
patent: 4275149 (1981-06-01), Litman et al.
patent: 4277437 (1981-07-01), Maggio
patent: 4366241 (1982-12-01), Tom et al.
patent: 5194596 (1993-03-01), Tischer et al.
patent: 5350836 (1994-09-01), Kopchick et al.
patent: 5807826 (1998-09-01), Goodman et al.
patent: 6433155 (2002-08-01), Umansky et al.
patent: 7045596 (2006-05-01), Umansky et al.
patent: 7045604 (2006-05-01), Umansky et al.
patent: 2007/0071751 (2007-03-01), Umansky et al.
patent: 2007/0082371 (2007-04-01), Umansky et al.
patent: 2007/0299005 (2007-12-01), Umansky et al.
patent: 2229436 (1998-11-01), None
patent: 879887 (1998-11-01), None
patent: 4 144686 (1992-05-01), None
patent: WO 93/04169 (1993-03-01), None
patent: WO 95/13701 (1995-05-01), None
patent: WO 95/15173 (1995-06-01), None
patent: WO 96/05232 (1996-02-01), None
patent: WO 96/39170 (1996-12-01), None
patent: WO 9813493 (1998-04-01), None
patent: WO 98/35043 (1998-08-01), None
patent: WO 9835043 (1998-08-01), None
Skolnick et al. (Trends in Biotechnology 2000; 18: 34-39).
Bowie et al. (Science. 1990; 257: 1306-1310).
Burgess et al. (Journal of Cell Biology 1990; 111: 2129-2138).
Lazar et al. (Molecular and Cellular Biology, 1988, 8: 1247-1252).
Luque et al. (Biochemistry. Nov. 19, 2002; 41 (46): 13663-13671).
Vucic et al. (J. Biol. Chem. Dec. 18, 1998; 273 (51): 33915-33921).
Takada et al. (Mol. Endocrinol. 2000; 14 (5): 733-740).
Guo et al. (Proc. Natl. Acad. Sci. USA. Jun. 22, 2004; 101 (25): 9205-9210).
Benjamin et al., Development, 1998, vol. 125, pp. 1591-1598.
Bergers et al., Current Opinion in Genetics and Development, 2000, vol. 10, pp. 120-127.
Bork, Genome Research, 2000, vol. 10, pp. 398-400.
Bork, Trends in Genetics, 1996, vol. 12, pp. 425-427.
Brenner, Trends in Genetics, 1999, vol. 15, pp. 132-133.
Cowled et al, Cancer Research, Feb. 15, 1987, vol. 47, pp. 971-974.
Doerks et al., Trends in Genetics, 1998, vol. 14, pp. 248-250.
Fukuhara et al., J. Clin. Endocrinol. Metab. 2002, vol. 87, Issue 4, pp. 1729-1736.
Gilhar et al., “Ageing of human epidermis: the role of apoptosis, Fas and telomerase”, Br. J. Dermatol, Jan. 2004, vol. 150, Issue 1, pp. 56-63.
Gillies et al. Human Antibodies and Hybridomas, 1990, 1(1): 47-54.
Gura, Science, 1997, vol. 278, pp. 1041-1042.
Han et al., J. Biol. Chem., Jan. 23, 2004, vol. 279, Issue 4, pp. 2832-2840.
Ibragimova and Wade, Biophysical Journal, Oct. 1999, vol. 77, pp. 2191-2198.
Joesting et al., Cancer Res., Nov. 15, 2005, vol. 65, No. 22, pp. 10423-10430.
Jones et al., Invest. Ophthalmol. Vis. Sci., May 2000, vol. 41, No. 6, pp. 1297-1301.
Kelland, Eur. J. Cancer, Apr. 2004, vol. 40, No. 6, pp. 827-836.
Lee et al., Breast Cancer Res. Treat., Nov. 2006, vol. 100, Issue 1, pp. 49-58.
Lin et al., Biochemistry USA, 1975, vol. 14, pp. 1559-1563.
Massague, Cell, 1987, vol. 49, pp. 437-438.
McBride et al., Clin. Chem, 1989, vol. 35, No. 11, pp. 2196-2201.
Nojima et al., Oncogene, 2007, vol. 26, pp. 4699-4713.
Pilbeam et al., Bone, 1993, Vo. 14, pp. 717-720.
Riva, Anticancer Research, 2000, vol. 20, pp. 3363-4472.
Roth et al., Oncogene, 2000, vol. 19, pp. 4210-4220.
Saijo et al., Cancer Sci, Oct. 2004, vol. 95, Issue 10, pp. 772-776.
Schwartz et al., Proc Natl Acad Sci USA, 1987, vol. 84, pp. 6408-6411.
Smith, Nature Biotechnology, 1997, vol. 15, pp. 1222-1223.
Suggitt et al., Clinical Cancer Research, Feb. 1, 2005, vol. 11, pp. 971-981.
Suzuki et al., Br. J. Cancer, Mar. 2008, vol. 98, Issue 6, pp. 1147-1156.
Takagi et al., J. Gastroenterol., 2008, vol. 43, Issue 5, pp. 378-389.
Tao, et al. The Journal of Immunology, 1989, 143(8): 2595-2601.
Tassone et al., Int. J. Oncol. 2005, vol. 26, pp. 1257-1263.
Umansky et al. “Post-ischemic apoptotic death of rat neonatal cardiomyocytes”, Cell Death Differ, 1995, vol. 2 No. 4, pp. 235-241.
Vukicevic et al., PNAS USA, 1996, vol. 93, pp. 9021-9026.
Wang et al., Anticancer Res., 2005, vol. 25, pp. 2367-2380.
Zeimet et al., Lancet, Jul. 2003, vol. 4, pp. 415-422.
Ameisen et al.,Immunol. Today, 12:102-105 (1991).
Ausubel et al., eds.,Current Protocols in Molecular Biology(1987) John Wiley & Sons, Inc.
Bates et al.,J. Cell Biol., 125:403-415 (1994).
Bhanot et al.,Nature, 382:225-230 (1996).
Boudreau et al.,Science, 267:891-893 (1995).
Chan et al.,J. Biol. Chem., 267:25202-25207 (1992).
Chomczynski et al.,Anal. Biochem., 162:156-159 (1987).
Cohen et al.,Ann. Rev. Immunol., 10:267-293 (1992).
Coligan et al., eds.Current Protocols in Immunology, (1991) John Wiley & Sons, Inc.
Cook et al.,EMBO J., 15:4526-4536 (1996).
Dann, C.E. et al., “Insights into Wnt binding and signaling from the structures of two Frizzled cysteine-rich domains”Nature412:86-90 (2001).
Duke et al.,Lymphokine Res., 5:289-299 (1986).
Feinberg et al.,Analytical Biochem., 137:266-267 (1984).
Finch et al.,Proc. Nat'l Acad. Sci. USA, 94:6770-6775 (1997).
Freshney, ed.,Animal Cell Culture, a practical approach, (1987) IRL Press, Oxford, England.
Gacesa et al.,Vectors Essential Data(1994) John Wiley & Sons Ltd., West Sussex, UK.
Gait, ed.,Oligonucleotide Synthesis, a practical approach(1984) IRL Press, Oxford, England.
Gavin et al.,Genes and Development, 4:2319-2332 (1990).
Gerschenson et al.,FASEB J.6:2450-2455 (1992).
Hannum et al.,T. Biochem. Sci., 20:73-77 (1995).
Harlow et al.,Antibodies. A laboratory Manual, (1988) Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
Hillier et al., Accession No. AA024771 (1996).
Hillier et al., Accession No. H16121 (1995).
Hillier et al., Accession No. H14917 (1995).
Hillier et al., Accession No. W92531 (1996).
Hillier et al., “The Washington University Merck EST project, AC H87071,” (Nov. 22, 1995), Heidelberg, XP002054775, 2 pages total.
Hillier et al., “The Washington University Merck EST project, AC H45312,” (Nov. 18, 1995), Heidelberg, XP002057808, 1 page total.
Hoang et al.,J. Biol. Chem., 271:26131-26137 (1996).
Hockenberry et al.,Cell, 75:241-251 (1993).
Hu et al.,Biochem. Biophys. Res. Comm., 247:287-293 (1998).
Ingham, Phillip W. “Has the quest for a Wnt receptor finally frizzled out?”Trends in Genetics12: 382-384 (1996).
Kanter et al.,Biochem. Biophys. Res. Comm., 118:392-399 (1984).
Kiefer et al.,Biochem. Biophys. Res. Comm., 176:219-225 (1991).
Kolesnick et al.,J. Esp. Med., 181:1949-1952 (1995).
Korinek et al.,Science, 275:1784-1792 (1997).
Kozopas et al.,Proc. Natl. Acad. Sci. USA, 90:3516-3520 (1993).
Kruman et al.,J. Cell. Physicol., 148:267-273 (1991).
Leyns et al.,Cell, 88:747-756 (1997).
Lichtenstein et al.,Anal. Biochem., 207:280-284 (1992).
Marra et al., The Washington University HHMI Mouse EST Project, AC W58777 (Jun. 9, 1996), Heidelberg, XP002057807, 2 pages total.
Melkonyan et al.,Proc. Natl. Acad. Sci. USA, 94:13636-13641 (1997).
Melkonyan, “A new family of secreted apoptosis-related proteins” (Abstract from Conference on Cell Cycle Control & Apoptosis: Basic Mechanisms & Novel Therapies, Jun. 30-Jul. 1, 1997, London, UK).
Melkonyan, “A new family of apoptosis-related genes” (Abstract from Conference on Apoptosis-Practical Applications and Novel Therapies, Nov. 20-21, 1997, Boston, MA).
Miller et al., eds.Gene Transfer Vectors for Mammalian Cells(1987) Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
Miller et al.
Melkonyan Hovsep
Umansky Samuil
Genentech Inc.
Rawlings Stephen L
Sheridan & Ross P.C.
LandOfFree
Family of genes encoding apoptosis-related peptides,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Family of genes encoding apoptosis-related peptides,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Family of genes encoding apoptosis-related peptides,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4093956